DELL'ORO, RAFFAELLA
 Distribuzione geografica
Continente #
NA - Nord America 9.378
EU - Europa 4.371
AS - Asia 1.902
SA - Sud America 14
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 7
Totale 15.692
Nazione #
US - Stati Uniti d'America 9.254
SE - Svezia 776
IT - Italia 752
SG - Singapore 730
DE - Germania 709
CN - Cina 654
IE - Irlanda 638
RU - Federazione Russa 533
UA - Ucraina 359
HK - Hong Kong 300
GB - Regno Unito 203
CA - Canada 121
FI - Finlandia 101
AT - Austria 87
VN - Vietnam 64
IN - India 56
FR - Francia 53
NL - Olanda 39
DK - Danimarca 38
BE - Belgio 27
JP - Giappone 24
TR - Turchia 22
ID - Indonesia 16
CZ - Repubblica Ceca 15
IR - Iran 10
BR - Brasile 8
RO - Romania 8
AU - Australia 7
EU - Europa 7
KR - Corea 5
BG - Bulgaria 4
KE - Kenya 4
LT - Lituania 4
MY - Malesia 4
CH - Svizzera 3
ES - Italia 3
GR - Grecia 3
MU - Mauritius 3
PE - Perù 3
PL - Polonia 3
BH - Bahrain 2
CL - Cile 2
DO - Repubblica Dominicana 2
HR - Croazia 2
LK - Sri Lanka 2
MG - Madagascar 2
PH - Filippine 2
PK - Pakistan 2
PT - Portogallo 2
RS - Serbia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
GE - Georgia 1
HU - Ungheria 1
IL - Israele 1
KH - Cambogia 1
LV - Lettonia 1
ME - Montenegro 1
MK - Macedonia 1
MN - Mongolia 1
MX - Messico 1
NG - Nigeria 1
NO - Norvegia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TN - Tunisia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 15.692
Città #
Ann Arbor 1.870
Fairfield 898
Woodbridge 884
Dublin 613
Houston 608
Chandler 587
Singapore 587
Frankfurt am Main 518
Wilmington 460
Ashburn 412
Jacksonville 402
Seattle 340
Hong Kong 297
Dearborn 267
New York 266
Cambridge 235
Princeton 210
Milan 197
Santa Clara 195
Nanjing 107
Lawrence 104
Altamura 94
Shanghai 88
Beijing 87
Vienna 86
Lachine 63
San Diego 56
Lissone 46
Nanchang 41
Dong Ket 40
Boardman 34
Andover 32
Guangzhou 31
Helsinki 31
Shenyang 31
Hebei 30
Changsha 27
Fremont 25
London 25
Falls Church 24
Toronto 23
Brussels 22
Rome 21
Tianjin 21
Jinan 20
Jiaxing 19
Norwalk 19
Kunming 18
Munich 18
Ningbo 17
Hangzhou 16
Ottawa 15
Sacramento 15
Brno 14
Cinisello Balsamo 14
Jakarta 14
Nürnberg 14
Hefei 13
Los Angeles 13
Monza 13
San Mateo 13
Huizen 11
Zhengzhou 11
Auburn Hills 10
Pune 10
Edmonton 8
Fuzhou 8
Philadelphia 8
Redmond 8
Amsterdam 7
Busto Arsizio 7
Groningen 7
Padova 7
Bergamo 6
Carate Brianza 6
Detroit 6
Kiev 6
Leawood 6
Malgesso 6
Mountain View 6
Romola 6
San Francisco 6
University Park 6
Winnipeg 6
Akatsuka-shinmachi 5
Dallas 5
Esslingen am Neckar 5
Lappeenranta 5
New Delhi 5
Reggio Emilia 5
São Paulo 5
Taiyuan 5
Vimercate 5
Washington 5
Assago 4
Atlanta 4
Bologna 4
Changchun 4
Chicago 4
Florence 4
Totale 11.542
Nome #
Heart rate as a sympathetic marker during acute adrenergic challenge 302
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 261
Sympathetic Neural Overdrive in the Obese and Overweight State: Meta-Analysis of Published Studies 245
Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction. 231
Severe systemic cytomegalovirus infection in an immunocompetent patient outside the intensive care unit: a case report 194
Excessive sympathetic activation in heart failure with obesity and metabolic syndrome: characteristics and mechanisms 193
Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome 191
Regional differences in sympathetic activation in lean and obese normotensive individuals with obstructive sleep apnoea 189
Sustained sympathoinhibitory effects of cardiac resynchronization therapy in severe heart failure 188
Structural alterations of the retinal microcirculation in the "prehypertensive" high- normal blood pressure state 188
Patterns of regional sympathetic nerve traffic in preascitic and ascitic cirrhosis 187
Sympathetic overdrive in the metabolic syndrome: meta-analysis of published studies 187
It is never too late for a genetic disease: a case of a 79-year-old man with persistent hypokalemia 186
Sympathetic and baroreflex abnormalities in the uncomplicated prediabetic state 186
Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome. 184
Angiotensin-sympathetic system interactions in cardiovascular and metabolic disease 183
Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values 183
Adrenergic and reflex abnormalities in obesity-related hypertension 178
Cardiac, neuroadrenergic, and portal hemodynamic effects of prolonged aldosterone blockade in postviral child a cirrhosis 175
Relationships between diuretic-related hyperuricemia and cardiovascular events: data from the URic acid Right for heArt Health study 174
Structural and functional alterations of subcutaneous small resistance arteries in severe human obesity 173
Alterations in sympathetic nerve traffic in genetic haemochromatosis before and after iron depletion therapy: A microneurographic study 173
Threshold and Target for Blood Pressure Lowering in the Elderly 171
Prevalence of cardiovascular risk factors in an unselected Italian population. Results of the CardioLab Project 2004-2008 170
Short- and long-term neuroadrenergic effects of moderate dietary sodium restriction in essential hypertension 168
Neurogenic abnormalities in masked hypertension 168
Long-term sympathoinhibitory effects of surgically induced weight loss in severe obese patients 167
Multicenter Randomized Double-Blind Comparison of Nebivolol plus HCTZ and Irbesartan plus HCTZ in the Treatment of Isolated Systolic Hypertension in Elderly Patients: Results of the NEHIS Study 166
Sympathetic and reflex alterations in systo-diastolic and systolic hypertension of the elderly 165
Effects of hypertension and obesity on the sympathetic activation of heart failure patients 165
Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives 165
Sympathetic nerve traffic and baroreflex function in optimal, normal, and high-normal blood pressure states 165
Role of ambulatory blood pressure monitoring in resistant hypertension 164
Cardiovascular risk and adrenergic overdrive in the metabolic syndrome 161
Sympathetic Nerve Traffic and Arterial Baroreflex Function in Apparent Drug-Resistant Hypertension 161
Primary and secondary prevention of stroke by antihypertensive treatment in clinical trials 159
Response to possible difference in the sympathetic activation on extreme dippers with or without exaggerated morining surge 153
Long-term Saxagliptin Treatment Improves Endothelial Function but not Pulse Wave Velocity and Intima-Media Thickness in Type 2 Diabetic Patients 151
Autonomic Cardiovascular Alterations in Chronic Kidney Disease: Effects of Dialysis, Kidney Transplantation, and Renal Denervation 150
Identification of the Uric Acid Thresholds Predicting an Increased Total and Cardiovascular Mortality Over 20 Years 149
Total cardiovascular risk, blood pressure variability and adrenergic overdrive in hypertension: evidence, mechanisms and clinical implications 147
Extreme dipping: Always means nocturnal hypotension? 147
Multicentre randomised, double blind, evaluation of nebivolol plus HCTZ and irbesartan plus HCTZ in the treatment of systolic hypertension in the elderly: the NEHIS Study 144
Sympathetic neural abnormalities in type 1 and type 2 diabetes: a systematic review and meta-analysis 144
Prognostic value of serum uric acid: new-onset in and out-of-office hypertension and long-term mortality 143
Reduced Insulin Sensitivity is Associated with Adrenergic Overdrive Independently on Obesity and Hypertension 142
Sympathetic and baroreflex function in hypertensive or heart failure patients with ventricular arrhythmias 140
How to assess sympathetic nervous system activity in clinical practice 140
Diurnal blood pressure variation and sympathetic activity 138
Reproducibility patterns of plasma norepinephrine and muscle sympathetic nerve traffic in human obesity 137
Novel Antihypertensive Therapies: Renal Sympathetic Nerve Ablation and Carotid Baroreceptor Stimulation 136
Pheochromocytoma as a Clinical Model of Peripheral Sympathetic Overdrive: Old and New Findings 135
Clinical correlates and subclinical cardiac organ damage in different extreme dipping patterns 135
Salt intake and sympathetic activity - Response 133
Sympathetic and baroreflex cardiovascular control in hypertension-related left ventricular dysfunction 132
Response to sympathetic activity, heart failure, obesity, and metabolic syndrome: Is there any role for obstructive sleep apnea? 131
Sympathetic nerve traffic, insulin resistance and baroreflex control of circulation in patients with resistant hypertension 131
Left ventricular hypertrophy in isolated and dual masked hypertension 131
Early sympathetic activation in the initial clinical stages of chronic renal failure 130
The "J curve" problem revisited: old and new findings 130
Restoration of normal sympathetic neural function in heart failure following baroreflex activation therapy: final 43-month study report 130
Baroreflex activation therapy systems: current status and future prospects 129
Relationship among morning blood pressure surge, 24-hour blood pressure variability, and cardiovascular outcomes in a white population 128
Sympathetic neural overdrive in congestive heart failure and its correlates: systematic reviews and meta-analysis 125
Sympathetic activation in congestive heart failure: Evidence, consequences and therapeutic implications 124
Retinal arteriolar narrowing as marker of renal dysfunction: potential value and limitations 124
High heart rate amplifies the risk of cardiovascular mortality associated with elevated uric acid 123
Adrenergic, metabolic, and reflex abnormalities in reverse and extreme dipper hypertensives 120
Sympathetic activation in obesity: a noninnocent bystander 118
Blood pressure control and antihypertensive treatment 118
Long-term changes in left ventricular mass echocardiographic findings from a general population 118
Obstructive sleep apnea-dependent and -independent adrenergic activation in obesity 117
Different neuroadrenergic activation and baroreflex function in resistant and pseudoresistant hypertension: a microneurographic study 117
Predictive value of different indices of blood pressure variability on 117
Reduced insulin sensitivity is associated with adrenergic overdrive in hemochromatosis independently on obesity and hypertension 116
Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project 115
COVID-19, hypertension and cardiovascular diseases: Should we change the therapy? 113
Essential hypertension and the sympathetic nervous system 111
Limited reliability of heart rate as a sympathetic marker in chronic kidney disease 111
Muscle and skin sympathetic nerve traffic during physician and nurse blood pressure measurement 110
DIFFERING EFFECTS OF RENAL DENERVATION ON BLOOD PRESSURE AND SYMPATHETIC NERVE TRAFFIC: A SYSTEMATIC REVIEW AND META-ANALYSIS 108
Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: Results of the CROSS study 108
The PAMELA research project: a 25-year long journey 105
The neglected role of the electrocardiogram in the diagnostic work-up of hypertensive patients: a study in clinical practice 101
Adverse prognostic value of persistent office blood pressure elevation in White coat Hypertension 101
Sympathetic Neural Mechanisms Underlying Attended and Unattended Blood Pressure Measurement 101
Antihypertensive treatment and stroke prevention: From recent meta-analyses to the PRoFESS trial 98
Blood pressure control and cardiovascular risk profile in hypertensive patients from central and eastern European countries: results of the BP-CARE study 96
Differential sympathetic activation in muscle and skin neural districts in the metabolic syndrome 95
Effects of long-term Baroreflex activation in congestive heart failure 94
Metabolic syndrome and cardiometabolic risk: An update 92
Vascular inflammation and aortic stiffness relate to early left ventricular diastolic dysfunction in prehypertension 92
Serum uric acid levels threshold for mortality in diabetic individuals: The URic acid Right for heArt Health (URRAH) project 90
Association between the European Society of Cardiology/European Society of Hypertension Heart Rate Thresholds for Cardiovascular Risk and Neuroadrenergic Markers 88
Prognosti relevance of electrocardiographic tp-te interval in the general and in the hypertensive population: data from the pamela study 84
Nocturnal blood pressure: the dark side of white-coat hypertension 78
Effects of renal denervation on asymmetric dimethylarginine and sympathetic nerve traffic in resistant hypertensive patients 76
Amiodarone induced siadh: A case of rare and late onset side effects 74
White-Coat Hypertension Without Organ Damage: Impact on Long-Term Mortality, New Hypertension, and New Organ Damage 72
American versus european hypertension guidelines: The case of white coat hypertension 71
Totale 14.223
Categoria #
all - tutte 62.995
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.995


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.743 0 0 0 0 231 309 352 202 267 164 160 58
2020/20212.263 140 123 204 220 164 211 240 225 186 242 116 192
2021/20221.700 147 125 235 183 138 128 71 68 95 110 163 237
2022/20232.510 270 708 231 253 150 408 41 155 140 34 80 40
2023/20242.082 51 54 89 112 290 493 391 63 229 40 41 229
2024/20251.952 333 679 234 257 449 0 0 0 0 0 0 0
Totale 16.265